Effect of ADRB gene polymorphism on the efficacy and safety of tocolytic therapy with β2-adrenergic agonists in preterm birth
<p> <b>G.F. Proklova<sup>1</sup>, R.A. Chilova<sup>1</sup>, E.A. Sokova<sup>2</sup>, R.E. Kazakov<sup>2</sup>, E.V. Zhukova<sup>1</sup>, K.O. Akopov<sup>3</sup>, N.S. Trifonova<sup>1</sup></b> <...
Main Authors: | G.F. Proklova, Chilova R.A., E.A. Sokova, R.E. Kazakov, E.V. Zhukova, N.S. Trifonova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LCC «Medicine-Inform»
2020-09-01
|
Series: | РМЖ. Мать и дитя |
Online Access: | http://wchjournal.com/upload/iblock/189/189d2ad7c3acba9b9edac69763c1df3a.pdf |
Similar Items
-
Clinical Pharmacology Aspects of Some Tocolytic Drugs Used in Pregnant Women at Risk of Preterm Birth
by: E. A. Sоkоvа, et al.
Published: (2019-09-01) -
Modern tocolytic therapy in treatment of threatening preterm birth (literature review)
by: A V Van, et al.
Published: (2014-08-01) -
Assessment of the tocolytic nifedipine in preclinical primary models of preterm birth
by: Bridget M. Arman, et al.
Published: (2023-04-01) -
BRONCHODILATOR AND TOCOLYTIC FEATURES OF β<sub>2</sub>-ADRENOCEPTOR AGONISTS
by: S. Ya. Skachilova, et al.
Published: (2019-01-01) -
Effect of β<sub>2</sub>-adrenergic receptor gene (<it>ADRB2)</it> 3′ untranslated region polymorphisms on inhaled corticosteroid/long-acting β<sub>2</sub>-adrenergic agonist response
by: Ambrose Helen J, et al.
Published: (2012-05-01)